Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.
Clinical trial NCT00522067 · COMPLETED
Trial details
- NCT number
- NCT00522067
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2007-07-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.